Dr. Philip J. Gold MD
USINFO | 2013-11-28 14:30

Medical Oncologist

Contact Information
1725 W Harrison St
Suite 1010
Chicago, IL 60612
Phone: (312) 942-5904

Specialty & Clinical Interests
Medical Oncologist: General Oncology

Hospital Affiliation
Rush University Medical Center
Education & Medical Training
Rush University Medical Center
Residency, Internal Medicine, 1983 - 1987
Rush Medical College
Class of 1983

Certifications & Licensure
American Board of Internal Medicine
Certified 2014 years in Internal Medicine
American Board of Internal Medicine
Certified 2014 years in Medical Oncology
IL State Medical License
Active through 2014

Publications & Presentations
Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia.
Waldmann, T. A.,Conlon, K. C.,Stewart, D. M.,Worthy, T. A.,Janik, J. E.,Fleisher, T. A.,Albert, P. S.,Figg, W. D.,Spencer, S. D.,Raffeld, M.,Decker, J. R.,Goldman, C. K.,Bryant, B. R.,Petrus, M. N.,Creekmore, S. P.,Morris, J. C.
Markedly additive anti-tumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T cell leukemia.
Chen, J.,Pise-Masison, C. A.,Shih, J. H.,Morris, J. C.,Janik, J. E.,Conlon, K. C.,Keating, A.,Waldmann, T. A.
Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas.
Davis, M., Conlon, K., Bohac, G. C., Barcenas, J., Leslie, W., Watkins, L., Lamzabi, I., Deng, Y., Li, Y., Plate, J. M.
 
 

美闻网---美国生活资讯门户
©2012-2014 Bywoon | Bywoon